HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Robert H. Messier, Jr Richard A. Hopkins Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Messier, R. H. Articles by Hopkins, R. A. Search for Related Content PubMed PubMed Citation Articles by Messier, R. H., Jr Articles by Hopkins, R. A.

J Thorac Cardiovasc Surg 1999;118:36-49
© 1999 Mosby, Inc.

SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE

INTERSTITIAL CELLULAR AND MATRIX RESTORATION OF CARDIAC VALVES AFTER CRYOPRESERVATION

From The Departments of Surgery of the Washington, DC, Veterans Affairs Medical Center, Georgetown University Medical Center, Washington, DC, Brown University, Providence, RI, and The Collis Cardiac Surgical Research Laboratory of the Lifespan Academic Medical Center, Providence, RI.

Supported in part by research grants from The American Heart Association and Lifenet.

Address for reprints: Richard A. Hopkins, MD, Chief, Cardiothoracic Surgery, Brown University School of Medicine, The Miriam Hospital, 164 Summit Ave, Providence, RI 02906.

Objectives: We previously characterized the porcine aortic leaflet interstitial cell phenotype as having both synthetic and contractile characteristics; that is, it is a myofibroblast. In this study we hypothesized (1) that the cryopreservation of aortic valves causes a significant reduction in cell density, (2) that it simultaneously causes alterations in representative components of extracellular matrix, and (3) that both of these processes are reversible.
Methods: Seventy-two leaflets from 24 porcine aortic valves were studied. Whole valves were subjected to variable lengths of preharvest ischemia (group 1), ischemia followed by processing analogous to clinical methods (group 2), and ischemia followed processing with an organ culture type of resuscitation (group 3). Vital dye exclusion by cells enzymatically dispersed from leaflets was used to quantify viability. Electron and light microscopy, immunohistochemical assay, and a silicone rubber substratum contractility assay were used both in dispersed cell preparations and in leaflet cross sections to examine structural, ultrastructural, and functional changes across the 3 groups through a range of preharvest ischemic times.
Results: Results indicated that harvest ischemic periods between 2 and 24 hours after donor death were not responsible for cell number reductions. During this interval overt dissolution of chondroitin sulfate simultaneous with a relative sparing of fibronectin was evidenced by immunohistochemical staining. Although not reduced in number, ischemic interstitial cells did show significant ultrastructural evidence of injury and suppressed monoclonal binding to vimentin and –smooth muscle actin. After cryopreservation, viable cell numbers were always markedly reduced at all ischemic intervals and damage to both soluble extracellular matrix components and cell ultrastructure was increased. At all time and processing points, however, some retention of matrix secretory and cellular contractile capabilities was observed among the surviving cells. After the extended periods of preharvest ischemia (2-24 hours) followed by processing, a restitution of functioning cells was accomplished by means of whole-leaflet incubation in 15% fetal bovine serum.
Conclusions: After application of the described methods, new cells within restored intact leaflets as well as in single-cell preparations demonstrated normal ultrastructure and contractile and synthetic functions (normal phenotypic expression). If functioning leaflet interstitial cells can contribute to homograft durability, bioengineering methods for pretransplantation cell repopulation could be refined with these techniques and applied to clinical valve transplantation. (J Thorac Cardiovasc Surg 1999; 118:36-49)

This article has been cited by other articles:

				R. Hopkins, H. Gitter, J. Stave, A. Bert, and M. Atalay Stable partial dehiscence of aortic homograft inserted freehand by using the subcoronary intra-aortic root noncoronary sinus Ross scallop inclusion technique J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 214 - 216. [Full Text] [PDF]

				K. Schenke-Layland, J. Xie, S. Heydarkhan-Hagvall, S. F. Hamm-Alvarez, U. A. Stock, K. G.M. Brockbank, and W. R. MacLellan Optimized Preservation of Extracellular Matrix in Cardiac Tissues: Implications for Long-Term Graft Durability Ann. Thorac. Surg., May 1, 2007; 83(5): 1641 - 1650. [Abstract] [Full Text] [PDF]

				K. Schenke-Layland, N. Madershahian, I. Riemann, B. Starcher, K.-J. Halbhuber, K. Konig, and U. A. Stock Impact of Cryopreservation on Extracellular Matrix Structures of Heart Valve Leaflets. Ann. Thorac. Surg., March 1, 2006; 81(3): 918 - 926. [Abstract] [Full Text] [PDF]

				N. A. Rice and L. A. Leinwand Skeletal myosin heavy chain function in cultured lung myofibroblasts J. Cell Biol., October 13, 2003; 163(1): 119 - 129. [Abstract] [Full Text] [PDF]

				R. J. F. Baskett, M. A. Nanton, A. E. Warren, and D. B. Ross Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 232 - 238. [Abstract] [Full Text] [PDF]

				T. Murakawa, J. Nakajima, M. Ono, A. Murakami, Y. Suematsu, and S. Takamoto Allogenicity of cryopreserved human fibroblasts: Cryopreservation does not downregulate the allogenicity of fibroblasts making up the matrices of allografts J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 712 - 719. [Abstract] [Full Text] [PDF]